News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
337,028 Results
Type
Article (18026)
Company Profile (71)
Press Release (318931)
Section
Business (95071)
Career Advice (1371)
Deals (18283)
Drug Delivery (42)
Drug Development (53548)
Employer Resources (64)
FDA (8702)
Job Trends (7390)
News (174226)
Policy (15007)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
Academia (1287)
Accelerated approval (1)
Adcomms (11)
Allergies (55)
Alliances (19745)
ALS (52)
Alzheimer's disease (727)
Antibody-drug conjugate (ADC) (80)
Approvals (8736)
Artificial intelligence (135)
Autoimmune disease (10)
Automation (7)
Bankruptcy (138)
Best Places to Work (6348)
BIOSECURE Act (5)
Biosimilars (62)
Biotechnology (54)
Bladder cancer (45)
Brain cancer (23)
Breast cancer (207)
Cancer (1430)
Cardiovascular disease (97)
Career advice (1067)
Career pathing (11)
CAR-T (79)
Cell therapy (252)
Cervical cancer (12)
Clinical research (44848)
Collaboration (490)
Compensation (292)
Complete response letters (9)
COVID-19 (2180)
CRISPR (23)
C-suite (103)
Cystic fibrosis (48)
Data (1441)
Denatured (4)
Depression (25)
Diabetes (154)
Diagnostics (3585)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (12)
Drug discovery (74)
Drug pricing (29)
Drug shortages (10)
Duchenne muscular dystrophy (53)
Earnings (52569)
Editorial (14)
Employer branding (8)
Employer resources (55)
Events (53420)
Executive appointments (375)
FDA (9427)
Featured Employer (12)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (419)
Gene editing (55)
Generative AI (10)
Gene therapy (172)
GLP-1 (432)
Government (2168)
Grass and pollen (3)
Guidances (37)
Healthcare (9409)
Huntington's disease (16)
IgA nephropathy (18)
Immunology and inflammation (63)
Indications (21)
Infectious disease (2260)
Inflammatory bowel disease (73)
Inflation Reduction Act (8)
Influenza (32)
Intellectual property (45)
Interviews (251)
IPO (10495)
IRA (15)
Job creations (1427)
Job search strategy (944)
Kidney cancer (10)
Labor market (16)
Layoffs (216)
Leadership (9)
Legal (2667)
Liver cancer (50)
Lung cancer (208)
Lymphoma (111)
Machine learning (2)
Management (21)
Manufacturing (136)
MASH (50)
Medical device (6580)
Medtech (6580)
Mergers & acquisitions (8156)
Metabolic disorders (396)
Multiple sclerosis (48)
NASH (17)
Neurodegenerative disease (54)
Neuropsychiatric disorders (18)
Neuroscience (1035)
NextGen: Class of 2025 (2740)
Non-profit (2273)
Northern California (1679)
Now hiring (6)
Obesity (196)
Opinion (103)
Ovarian cancer (48)
Pain (60)
Pancreatic cancer (62)
Parkinson's disease (83)
Partnered (6)
Patents (100)
Patient recruitment (58)
Peanut (32)
People (19607)
Pharmaceutical (18)
Pharmacy benefit managers (3)
Phase I (11875)
Phase II (18747)
Phase III (18354)
Pipeline (739)
Podcasts (24)
Policy (32)
Postmarket research (1426)
Preclinical (4270)
Press Release (20)
Prostate cancer (71)
Psychedelics (14)
Radiopharmaceuticals (127)
Rare diseases (225)
Real estate (1977)
Recruiting (26)
Regulatory (11339)
Reports (27)
Research institute (1171)
Resumes & cover letters (260)
Rett syndrome (3)
RNA editing (1)
RSV (29)
Schizophrenia (52)
Series A (71)
Series B (45)
Service/supplier (8)
Sickle cell disease (36)
Southern California (1449)
Special edition (16)
Sponsored (14)
Startups (1499)
Stomach cancer (5)
Supply chain (41)
The Weekly (20)
United States (13207)
Vaccines (479)
Venture capitalists (21)
Webinars (6)
Weight loss (120)
Women's health (19)
Worklife (9)
Date
Today (82)
Last 7 days (427)
Last 30 days (2204)
Last 365 days (23107)
2025 (4666)
2024 (22762)
2023 (24263)
2022 (30419)
2021 (32443)
2020 (30717)
2019 (22465)
2018 (16988)
2017 (17766)
2016 (15579)
2015 (18275)
2014 (13409)
2013 (10256)
2012 (10942)
2011 (11481)
2010 (9882)
Location
Africa (416)
Alabama (23)
Alaska (3)
Arizona (51)
Arkansas (8)
Asia (22697)
Australia (4143)
California (3770)
Canada (1160)
China (288)
Colorado (174)
Connecticut (194)
Delaware (104)
Europe (48756)
Florida (463)
Georgia (114)
Idaho (22)
Illinois (273)
India (13)
Indiana (183)
Iowa (4)
Japan (114)
Kansas (59)
Kentucky (5)
Louisiana (4)
Maine (36)
Maryland (420)
Massachusetts (2650)
Michigan (78)
Minnesota (212)
Mississippi (2)
Missouri (50)
Montana (12)
Nebraska (7)
Nevada (39)
New Hampshire (33)
New Jersey (1056)
New Mexico (7)
New York (977)
North Carolina (558)
North Dakota (4)
Northern California (1679)
Ohio (121)
Oklahoma (4)
Oregon (19)
Pennsylvania (711)
Puerto Rico (5)
Rhode Island (11)
South America (645)
South Carolina (7)
Southern California (1449)
Tennessee (51)
Texas (530)
Utah (87)
Virginia (79)
Washington D.C. (31)
Washington State (337)
West Virginia (1)
Wisconsin (40)
337,028 Results for "3 v biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Fluent BioSciences Debuts PIPseq™ V with Unique Molecular Counting Strategy
Fluent BioSciences, a leader in single-cell technology innovation, is proud to herald the launch of our latest product line, the PIPseq V 3' Single Cell RNA Sequencing Kits.
May 29, 2024
·
1 min read
Press Releases
Nielsen BioSciences Successfully Completes Enrollment into Phase 3 Trial of CANDIN for the Treatment of Common Warts
February 26, 2025
·
3 min read
Press Releases
Emalex Biosciences’ Lead Candidate Meets Primary and Secondary Endpoints in Phase 3 Tourette Syndrome Study
February 25, 2025
·
4 min read
Press Releases
Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025
January 22, 2025
·
2 min read
Biotech Beach
Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations
Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of DRAGEN™ v4.3, the latest version of its DRAGEN™ software, part of the Illumina Connected Software portfolio, for analysis of next-generation sequencing data.
June 11, 2024
·
5 min read
Press Releases
Forte Biosciences to Host R&D Day December 3, 2024
November 25, 2024
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q3 2024 Results and Highlights Progress on Varoglutamstat in Kidney Disease
December 10, 2024
·
13 min read
Press Releases
QIAGEN N.V. to release results for Q3 2024 and hold webcast
October 10, 2024
·
1 min read
Genetown
Foray Bioscience Raises $3M to Protect and Restore Natural Ecosystems with Biomanufacturing
Foray Bioscience , a startup sowing the seeds for plantless plant products, today announced it has raised $3 million in seed funding, led by ReGen Ventures.
June 25, 2024
·
3 min read
Press Releases
Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024
December 4, 2024
·
3 min read
1 of 33,703
Next
